Ginkgo Bioworks Holdings (DNA) Gross Margin (QoQ) (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) Gross Margin (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Ginkgo Bioworks Holdings 517.16 Mn 373.30 Mn 16.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4,074.00
Dec 31, 2025 -3,559.00
Sep 30, 2025 -1,021.00
Jun 30, 2025 -15.00
Mar 31, 2025 -598.00
Dec 31, 2024 -245.00
Sep 30, 2024 114.00
Jun 30, 2024 -341.00
Mar 31, 2024 -308.00
Dec 31, 2023 1,557.00
Sep 30, 2023 745.00
Jun 30, 2023 216.00
Mar 31, 2023 -17,813.00
Dec 31, 2022 19,316.00
Sep 30, 2022 -3,544.00
Jun 30, 2022 312.00
Mar 31, 2022 -155.00
Dec 31, 2021 2,106.00
Sep 30, 2021 1,072.00
Jun 30, 2021 -382.00